Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

RAPP - Rapport Therapeutics Inc.

IEX Last Trade
21.86
2.060   9.424%

Share volume: 108,481
Last Updated: Fri 30 Aug 2024 09:59:01 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$19.80
2.06
10.40%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-2.47%
1 Month
3.67%
3 Months
4.57%
6 Months
4.57%
1 Year
4.57%
2 Year
4.57%
Key data
Stock price
$21.86
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$16.55 - $28.08
52 WEEK CHANGE
$0.05
MARKET CAP 
795.538 M
YIELD 
N/A
SHARES OUTSTANDING 
36.576 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
3.39
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$94,606
AVERAGE 30 VOLUME 
$104,936
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news